Skip to main content

Table 2 Descriptive analysis of the total hospital cost and the out-of-pocket patient payments (n = 367)

From: Costs associated with febrile neutropenia in solid tumor and lymphoma patients – an observational study in Singapore

  

Total hospital cost

Out-of-pocket patient payments

Variables

No. (%)

per episode, 2012 US$

per episode, 2012 US$

  

Mean (±95% CI)

p value

Median

Mean (±95% CI)

p value

Median

All subjects

367 (100%)

4,193 (±414)

 

2,837

2,230 (±254)

 

1,405

Age in years

       

18-40

41 (11.2%)

5,160 (±1,791)

0.182 @

3,456

3,031 (±730)

0.001 @

2,468

41-60

202 (55.0%)

4,089 (±544)

2,723

2,105 (±303)

1,337

61-80

124 (33.8%)

4,044 (±624)

3,022

2,167 (±514)

1,369

Gender

       

Male

139 (37.9%)

5,286 (±864)

< 0.001 #

3,432

2,795 (±558)

0.006 #

1,510

Female

228 (62.1%)

3,527 (±389)

2,651

1,885 (±218)

1,334

Cancer type

       

Breast CA

135 (36.8%)

2,898 (±369)

< 0.001 @

2,208

1,567 (±249)

< 0.001 @

1,167

Lymphoma

79 (21.5%)

6,560 (±1,362)

4,159

3,389 (±827)

1,972

Gastrointestinal CA

39 (10.6%)

4,145 (±859)

3,432

1,927 (±541)

1,349

Head and Neck CA

34 (9.3%)

4,565 (±1,665)

3,150

2,502 (±867)

1,486

Lung CA

31 (8.4%)

3,353 (±912)

2,314

1,861 (±947)

1,097

Sarcoma

16 (4.4%)

3,857 (±1,119)

3,479

2,331 (±701)

2,194

Genitourinary CA

15 (4.1%)

4,898 (±2,803)

2,654

2,629 (±1,498)

1,340

Gynecologic CA

13 (3.5%)

4,615 (±1,482)

3,858

2,877 (±1,317)

2,251

Other/Unknown CA

5 (1.4%)

2,707 (±1,199)

2,359

1,403 (±677)

1,364

Therapeutic GCSF

       

No

48 (13.1%)

3,752 (±1,088)

0.064 #

2,392

1,544 (±384)

0.007 #

1,181

Yes

319 (86.9%)

4,267 (±450)

2,950

2,338 (±286)

1,487

Admission source

       

ED

195 (53.1%)

3,721 (±503)

< 0.001 @

2,577

1,979 (±259)

0.001 @

1,302

NCCS clinic

121 (33.0%)

3,671 (±594)

2,451

2,069 (±409)

1,377

Inpatient referral

51 (13.9%)

7,238 (±1,601)

4,436

3,570 (±1,163)

2,112

Severe sepsis

       

No

315 (85.8%)

3,590 (±350)

< 0.001 #

2,571

2,044 (±264)

< 0.001 #

1,283

Yes

52 (14.2%)

7,879 (±1,744)

6,105

3,358 (±772)

2,073

MASCC risk

       

Low

300 (81.7%)

3,790 (±412)

< 0.001 #

2,571

2,162 (±283)

0.034 #

1,316

High

67 (18.3%)

5,998 (±1,249)

4,436

2,533 (±574)

1,711

Ward class

       

Class A1

30 (8.2%)

5,879 (±1,875)

0.039 @

4,086

5,245 (±1,889)

< 0.001 @

3,828

Class B1

48 (13.1%)

3,699 (±784)

2,479

3,749 (±835)

2,512

Class B2

194 (52.9%)

3,855 (±540)

2,727

1,696 (±205)

1,256

Class C

95 (25.8%)

4,602 (±923)

3,185

1,600 (±313)

1,100

  1. ED = emergency department; NCCS = National Cancer Centre Singapore; CI = confidence interval; MASCC = Multinational Association of Supportive Care in Cancer; CA = cancer; @p value from ANOVA test; #p value from two sample t-test, assumed equal variance